Web Exclusives

Targeted therapies continue to change the treatment landscape, improving outcomes beyond traditional chemoimmunotherapy. Read More ›

Although most employers are not passing costs to employees, the COVID-19 pandemic has raised uncertainty throughout the entire healthcare system. Read More ›

An analysis of 4 studies finds that acalabrutinib does not increase the risk of developing heart problems for patients with CLL. Read More ›

A 5-year analysis of the MURANO study shows patients completing venetoclax treatment have long-term, durable responses. Read More ›

A systematic review of publications finds that patients with hematologic cancers who contract COVID-19 have an increased risk of death. Read More ›

As healthcare professionals continue to manage the effects of the COVID-19 pandemic, the introduction of a vaccine allows patients with cancer to approach 2021 with cautious optimism for a better year ahead. Read More ›

Khadijat Fatai-Banwo’s HER2-positive breast cancer diagnosis changed her outlook on the world and inspired her to become a leading voice in advocating for cancer care to be a national health priority in Nigeria. Read More ›

2020 was a hard year for everyone, including patients with cancer who faced new challenges in these unprecedented times. As we reflect on this difficult year, it’s important to practice gratitude actively. Read More ›

As we prepare for a socially distant holiday season, patients with cancer and their families can safely celebrate by participating in live video chats, phone calls, interactive games, and more. Read More ›

Pets and pet therapy can bring joy to patients with cancer during a physically and emotionally draining time, but it’s important to know the risks involved. Read More ›